Xtuit Pharmaceuticals

formerly XtuitClosed

Targeting the tumor microenvironment to overcome cancer drug resistance

Waltham, United States · Founded 2011 · $26.0M raised

Employees
11–50
Founded
2011
Business Model
B2B
Website
xtuit.com
Total Funding
$26.0M
Last Round
$22.0M Series AJun 2015
Rounds
3

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 5 investors for this company. The full record is or through the API.

About

XTuit Pharmaceuticals was a biopharmaceutical company developing novel microenvironment-activated therapeutics that targeted key mechanisms driving tumor hypoxia, decreased drug uptake, drug resistance, and diminished immune response. Founded in 2011 by Harvard professor Rakesh Jain, MIT professor Robert Langer, and Polaris Partners' Alan Crane, the Waltham, Massachusetts-based company focused its pipeline on the tumor microenvironment before ceasing operations after its last funding round in September 2016.

Summary

Xtuit Pharmaceuticals is a Biotech company based in Waltham, United States, founded in 2011. It has raised $26.0M in total across 3 rounds, most recently a $22.0M Series A round in Jun 2015. Investors include Polaris Partners, New Enterprise Associates and Arcus Ventures.

Funding History

Series ASeries AJun 2015
$22.0M

Sign up to see all 3 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Xtuit Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/xtuit-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/xtuit-pharmaceuticals" alt="Xtuit Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>